Income statement (kDKK)
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 413.04 | 457.25 | 447.52 | 391.41 |
| Employee benefit expenses | - 421.35 | - 447.80 | - 504.91 | - 430.50 |
| EBIT | -8.30 | 9.45 | -57.40 | -39.09 |
| Other financial expenses | -0.41 | -0.56 | -0.91 | -5.16 |
| Pre-tax profit | -8.71 | 8.88 | -58.30 | -44.25 |
| Income taxes | 1.26 | -3.23 | 11.29 | 8.29 |
| Net earnings | -7.45 | 5.66 | -47.02 | -35.95 |
Assets (kDKK)
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current trade debtors | 42.50 | 31.25 | 33.56 | |
| Current amounts owed by group member comp. | 1.26 | 9.32 | ||
| Current other receivables | 1.88 | 0.95 | 2.20 | 2.28 |
| Current deferred tax assets | 1.26 | 11.29 | 8.29 | |
| Short term receivables total | 3.15 | 44.71 | 44.74 | 53.46 |
| Cash and bank deposits | 135.10 | 56.37 | 18.02 | 30.17 |
| Cash and cash equivalents | 135.10 | 56.37 | 18.02 | 30.17 |
| Balance sheet total (assets) | 138.25 | 101.09 | 62.75 | 83.63 |
Equity and liabilities (kDKK)
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | -7.45 | -1.79 | -48.81 | |
| Profit of the financial year | -7.45 | 5.66 | -47.02 | -35.95 |
| Shareholders equity total | 32.55 | 38.21 | -8.81 | -44.76 |
| Non-current liabilities total | ||||
| Current loans from credit institutions | 78.20 | |||
| Current owed to group member | 1.96 | |||
| Short-term deferred tax liabilities | 3.23 | |||
| Other non-interest bearing current liabilities | 105.70 | 59.65 | 69.60 | 50.20 |
| Current liabilities total | 105.70 | 62.88 | 71.56 | 128.40 |
| Balance sheet total (liabilities) | 138.25 | 101.09 | 62.75 | 83.63 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.